Do analysts prefer SONX or ADGM?

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 405.63%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Adagio Medical 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25

Is SONX or ADGM more profitable?

Adagio Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat Adagio Medical's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Adagio Medical N/A -661.85% -73.35%

Is SONX or TMDIF more profitable?

Titan Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Titan Medical's return on equity of -82.31% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets Sonendo -92.74% -184.01% -68.60% Titan Medical N/A -82.31% -51.47%

Do analysts recommend ZJYL or SONX?

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Jin Medical International 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has better valuation and earnings, ZJYL or SONX?

Jin Medical International has higher earnings, but lower revenue than Sonendo. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Jin Medical International $20.69M 12.81 $1.19M N/A N/A Sonendo $44.40M 0.06 -$60.92M -$71.12 N/A

Do analysts rate IRIX or SONX?

IRIDEX currently has a consensus target price of $3.00, suggesting a potential upside of 250.47%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts plainly believe IRIDEX is more favorable than Sonendo. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Sonendo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00

Which has higher valuation and earnings, IRIX or SONX?

IRIDEX has higher revenue and earnings than Sonendo. IRIDEX is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.28 -$4.44M -$0.19 N/A Sonendo $44.40M 0.06 -$60.92M -$71.12 N/A

Is IRIX or SONX more profitable?

IRIDEX has a net margin of -6.23% compared to Sonendo's net margin of -92.74%. IRIDEX's return on equity of 0.00% beat Sonendo's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% N/A -11.16% Sonendo -92.74% -184.01% -68.60%

Sonendo (SONX) Competitors

$0.55 -0.42 (-43.23%)

As of 02:13 PM Eastern

Compare

SONX vs. ADGM, TMDIF, ZJYL, IRIX, and NMTC

Should you buy Sonendo stock or one of its competitors? Sonendo's main competitors and comparable companies include Adagio Medical (ADGM), Titan Medical (TMDIF), Jin Medical International (ZJYL), IRIDEX (IRIX), and NeuroOne Medical Technologies (NMTC). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Sonendo compare to Adagio Medical?

Sonendo (NYSE:SONX) and Adagio Medical (NASDAQ:ADGM) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, media sentiment, earnings, risk, institutional ownership and valuation.

28.7% of Sonendo shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 7.9% of Sonendo shares are held by insiders. Comparatively, 7.8% of Adagio Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Adagio Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Sonendo's return on equity of -184.01% beat Adagio Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Adagio Medical	N/A	-661.85%	-73.35%

Adagio Medical has a consensus price target of $3.50, indicating a potential upside of 405.63%. Given Adagio Medical's stronger consensus rating and higher possible upside, analysts plainly believe Adagio Medical is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Adagio Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25

Sonendo has a beta of 1.81, indicating that its share price is 81% more volatile than the broader market. Comparatively, Adagio Medical has a beta of -0.15, indicating that its share price is 115% less volatile than the broader market.

Adagio Medical has lower revenue, but higher earnings than Sonendo. Adagio Medical is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.06	-$60.92M	-$71.12	N/A
Adagio Medical	$600K	25.62	-$25.08M	-$1.53	N/A

In the previous week, Adagio Medical had 4 more articles in the media than Sonendo. MarketBeat recorded 4 mentions for Adagio Medical and 0 mentions for Sonendo. Sonendo's average media sentiment score of 0.00 beat Adagio Medical's score of -0.28 indicating that Sonendo is being referred to more favorably in the media.

Company	Overall Sentiment
Sonendo	Neutral
Adagio Medical	Neutral

Summary

Adagio Medical beats Sonendo on 9 of the 16 factors compared between the two stocks.

How does Sonendo compare to Titan Medical?

Sonendo (NYSE:SONX) and Titan Medical (NASDAQ:TMDIF) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, institutional ownership, dividends, risk, earnings, media sentiment, analyst recommendations and profitability.

Titan Medical has lower revenue, but higher earnings than Sonendo. Sonendo is trading at a lower price-to-earnings ratio than Titan Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sonendo	$44.40M	0.06	-$60.92M	-$71.12	N/A
Titan Medical	$17.63M	0.95	$6.95M	$0.05	2.93

In the previous week, Sonendo's average media sentiment score of 0.00 equaled Titan Medical'saverage media sentiment score.

Company	Overall Sentiment
Sonendo	Neutral
Titan Medical	Neutral

Sonendo has a beta of 1.81, indicating that its share price is 81% more volatile than the broader market. Comparatively, Titan Medical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

28.7% of Sonendo shares are owned by institutional investors. Comparatively, 0.0% of Titan Medical shares are owned by institutional investors. 7.9% of Sonendo shares are owned by insiders. Comparatively, 0.0% of Titan Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Titan Medical has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Titan Medical's return on equity of -82.31% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sonendo	-92.74%	-184.01%	-68.60%
Titan Medical	N/A	-82.31%	-51.47%

Summary

Titan Medical beats Sonendo on 6 of the 11 factors compared between the two stocks.

How does Sonendo compare to Jin Medical International?

Jin Medical International (NASDAQ:ZJYL) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, dividends, media sentiment, valuation and risk.

28.7% of Sonendo shares are held by institutional investors. 7.9% of Sonendo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Jin Medical International has a beta of 7.34, indicating that its stock price is 634% more volatile than the broader market. Comparatively, Sonendo has a beta of 1.81, indicating that its stock price is 81% more volatile than the broader market.

Jin Medical International has higher earnings, but lower revenue than Sonendo.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Jin Medical International	$20.69M	12.81	$1.19M	N/A	N/A
Sonendo	$44.40M	0.06	-$60.92M	-$71.12	N/A

Jin Medical International has a net margin of 0.00% compared to Sonendo's net margin of -92.74%. Jin Medical International's return on equity of 0.00% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Jin Medical International	N/A	N/A	N/A
Sonendo	-92.74%	-184.01%	-68.60%

In the previous week, Jin Medical International had 3 more articles in the media than Sonendo. MarketBeat recorded 3 mentions for Jin Medical International and 0 mentions for Sonendo. Jin Medical International's average media sentiment score of 1.12 beat Sonendo's score of 0.00 indicating that Jin Medical International is being referred to more favorably in the media.

Company	Overall Sentiment
Jin Medical International	Positive
Sonendo	Neutral

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Jin Medical International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

Summary

Jin Medical International beats Sonendo on 9 of the 12 factors compared between the two stocks.

How does Sonendo compare to IRIDEX?

IRIDEX (NASDAQ:IRIX) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their valuation, dividends, institutional ownership, risk, media sentiment, earnings, profitability and analyst recommendations.

IRIDEX has higher revenue and earnings than Sonendo. IRIDEX is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.28	-$4.44M	-$0.19	N/A
Sonendo	$44.40M	0.06	-$60.92M	-$71.12	N/A

IRIDEX currently has a consensus target price of $3.00, suggesting a potential upside of 250.47%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts plainly believe IRIDEX is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

20.1% of IRIDEX shares are held by institutional investors. Comparatively, 28.7% of Sonendo shares are held by institutional investors. 8.6% of IRIDEX shares are held by company insiders. Comparatively, 7.9% of Sonendo shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

IRIDEX has a net margin of -6.23% compared to Sonendo's net margin of -92.74%. IRIDEX's return on equity of 0.00% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	N/A	-11.16%
Sonendo	-92.74%	-184.01%	-68.60%

IRIDEX has a beta of 0.66, suggesting that its share price is 34% less volatile than the broader market. Comparatively, Sonendo has a beta of 1.81, suggesting that its share price is 81% more volatile than the broader market.

In the previous week, IRIDEX had 1 more articles in the media than Sonendo. MarketBeat recorded 1 mentions for IRIDEX and 0 mentions for Sonendo. IRIDEX's average media sentiment score of 1.89 beat Sonendo's score of 0.00 indicating that IRIDEX is being referred to more favorably in the media.

Company	Overall Sentiment
IRIDEX	Very Positive
Sonendo	Neutral

Summary

IRIDEX beats Sonendo on 13 of the 16 factors compared between the two stocks.

How does Sonendo compare to NeuroOne Medical Technologies?

NeuroOne Medical Technologies (NASDAQ:NMTC) and Sonendo (NYSE:SONX) are both small-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, earnings, risk, profitability, media sentiment, valuation and dividends.

NeuroOne Medical Technologies has a net margin of -71.50% compared to Sonendo's net margin of -92.74%. NeuroOne Medical Technologies' return on equity of -115.61% beat Sonendo's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
NeuroOne Medical Technologies	-71.50%	-115.61%	-79.63%
Sonendo	-92.74%	-184.01%	-68.60%

In the previous week, NeuroOne Medical Technologies had 5 more articles in the media than Sonendo. MarketBeat recorded 5 mentions for NeuroOne Medical Technologies and 0 mentions for Sonendo. NeuroOne Medical Technologies' average media sentiment score of 0.77 beat Sonendo's score of 0.00 indicating that NeuroOne Medical Technologies is being referred to more favorably in the media.

Company	Overall Sentiment
NeuroOne Medical Technologies	Positive
Sonendo	Neutral

NeuroOne Medical Technologies presently has a consensus target price of $7.33, indicating a potential upside of 278.01%. Given NeuroOne Medical Technologies' stronger consensus rating and higher probable upside, equities research analysts plainly believe NeuroOne Medical Technologies is more favorable than Sonendo.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeuroOne Medical Technologies	1 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.40
Sonendo	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00

16.1% of NeuroOne Medical Technologies shares are owned by institutional investors. Comparatively, 28.7% of Sonendo shares are owned by institutional investors. 11.8% of NeuroOne Medical Technologies shares are owned by insiders. Comparatively, 7.9% of Sonendo shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

NeuroOne Medical Technologies has higher earnings, but lower revenue than Sonendo. NeuroOne Medical Technologies is trading at a lower price-to-earnings ratio than Sonendo, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
NeuroOne Medical Technologies	$12.10M	1.39	-$3.61M	-$0.85	N/A
Sonendo	$44.40M	0.06	-$60.92M	-$71.12	N/A

NeuroOne Medical Technologies has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market. Comparatively, Sonendo has a beta of 1.81, indicating that its stock price is 81% more volatile than the broader market.

Summary

NeuroOne Medical Technologies beats Sonendo on 11 of the 16 factors compared between the two stocks.

Get Sonendo News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SONX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

SONX vs. The Competition

Export

Metric	Sonendo	Healthcare Equipment & Supplies Industry	Healthcare Sector	NYSE Exchange
Market Cap	$2.63M	$5.95B	$7.06B	$24.33B
Dividend Yield	N/A	1.76%	2.57%	3.68%
P/E Ratio	-0.01	26.22	269.06	30.78
Price / Sales	0.06	63.09	602.43	21.31
Price / Cash	N/A	33.92	70.48	32.80
Price / Book	0.01	6.10	12.91	6.82
Net Income	-$60.92M	$148.67M	$3.45B	$1.06B
7 Day Performance	-45.00%	1.84%	1.12%	0.55%
1 Month Performance	-32.93%	4.56%	1.79%	3.13%
1 Year Performance	N/A	8.67%	67.69%	18.71%

Sonendo Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
SONX Sonendo	N/A	$0.55 -43.2%	N/A	N/A	$2.63M	$44.40M	N/A	250	Gap Down
ADGM Adagio Medical	2.2985 of 5 stars	$0.73 -0.9%	$3.50 +378.1%	-45.7%	$16.41M	$600K	N/A	87	Earnings Report
TMDIF Titan Medical	N/A	$0.14 -6.9%	N/A	-61.9%	$15.82M	$17.63M	N/A	50	Gap Down
ZJYL Jin Medical International	1.3236 of 5 stars	$1.92 -13.1%	N/A	-74.9%	$15.09M	$20.69M	N/A	245	Positive News Short Interest Decrease
IRIX IRIDEX	2.6177 of 5 stars	$0.84 -0.5%	$3.00 +257.3%	-30.2%	$14.69M	$52.58M	N/A	120	Positive News Upcoming Earnings

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:SONX) was last updated on 8/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Sonendo (SONX) Competitors

SONX vs. ADGM, TMDIF, ZJYL, IRIX, and NMTC

How does Sonendo compare to Adagio Medical?

Summary

How does Sonendo compare to Titan Medical?

Summary

How does Sonendo compare to Jin Medical International?

Summary

How does Sonendo compare to IRIDEX?

Summary

How does Sonendo compare to NeuroOne Medical Technologies?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Sonendo (SONX) Competitors

SONX vs. ADGM, TMDIF, ZJYL, IRIX, and NMTC

How does Sonendo compare to Adagio Medical?

Do institutionals and insiders have more ownership in SONX or ADGM?

Is SONX or ADGM more profitable?

Do analysts prefer SONX or ADGM?

Which has more volatility & risk, SONX or ADGM?

Which has better earnings & valuation, SONX or ADGM?

Does the media refer more to SONX or ADGM?

Summary

How does Sonendo compare to Titan Medical?

Which has stronger valuation and earnings, SONX or TMDIF?

Does the media prefer SONX or TMDIF?

Which has more volatility & risk, SONX or TMDIF?

Do institutionals and insiders have more ownership in SONX or TMDIF?

Is SONX or TMDIF more profitable?

Summary

How does Sonendo compare to Jin Medical International?

Do institutionals and insiders believe in ZJYL or SONX?

Which has more risk and volatility, ZJYL or SONX?

Which has better valuation and earnings, ZJYL or SONX?

Is ZJYL or SONX more profitable?

Does the media favor ZJYL or SONX?

Do analysts recommend ZJYL or SONX?

Summary

How does Sonendo compare to IRIDEX?

Which has higher valuation and earnings, IRIX or SONX?

Do analysts rate IRIX or SONX?

Do insiders & institutionals believe in IRIX or SONX?

Is IRIX or SONX more profitable?

Which has more volatility and risk, IRIX or SONX?

Does the media prefer IRIX or SONX?

Summary

How does Sonendo compare to NeuroOne Medical Technologies?

Is NMTC or SONX more profitable?

Does the media refer more to NMTC or SONX?

Do analysts prefer NMTC or SONX?

Do institutionals & insiders believe in NMTC or SONX?

Which has better earnings & valuation, NMTC or SONX?

Which has more risk & volatility, NMTC or SONX?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

SONX vs. The Competition

Sonendo Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools